InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,972.38
(
-0.22%
)
US TECH 100
20,410.40
(
-0.39%
)
Dow Jones
43,885.38
(
-0.17%
)
Brent Oil
72.40
(
0.74%
)
Bitcoin
89,509.93
(
-1.16%
)
Post# of 253597
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rwwine

Send PM Follow Ignore
Followers 11
Posts 885
Boards Moderated 0
Alias Born 10/27/2003

rwwine

Re: DewDiligence post# 112884

Thursday, 01/20/2011 1:39:30 PM

Thursday, January 20, 2011 1:39:30 PM

Post# of 253597
"Many investors remain unconvinced that NVS/MNTA will receive FDA approval for generic Copaxone before Teva’s patents expire in 2014; for those investors, the patent case is mostly academic."

On the MNTA board....I expressed my views. Specifically thinking MNTA would recieve approval from the FDA by the end of 2011. In your view....do you think I'm too optimistic?

TIA
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up